List of All Articles with Tag 'am'

Amazon.com Inc. Chief Executive Officer Andy Jassy pulled off a financial double play this earnings season: generating strong

Donald Trump pleaded not guilty in court on Thursday after being arrested and arraigned for conspiring to overturn the 2020 presidential election, the latest in his third – and potentially most serious – criminal case. The former president was indicted Monday on four charges as part of special counsel Jack Smith’s investigation into the alleged conspiracy and the 6 January Capitol riot. The indictment also described six unnamed co-conspirators, though observers have credibly guessed most of their identities. The former president has railed against the indictment, calling for the “fake” case to be moved out of Washington DC where he claims it is “IMPOSSIBLE to get a fair trial”. The case has been assigned to US district judge Tanya Chutkan, a Barack Obama appointee. The next hearing is scheduled for 28 August. Read Trump’s full indictment from the January 6 grand jury Read More Trump appears to stumble over his name and age at arraignment Will Donald Trump go to prison? Trump was told not to talk to witnesses in 2020 election conspiracy case. That could be a challenge. What is an arraignment? Here’s what to expect following Trump’s indictment

About 15 miles south of Martha’s Vineyard, Massachusetts, a massive structure emerges from the Atlantic Ocean. Nearby it

Florida governor and 2024 presidential candidate Ron DeSantis said on Friday that Donald Trump’s claims that the 2020 election was rigged are not true. “All those theories that were put out did not prove to be true,” Mr DeSantis told The New York Times during a campaign stop in Iowa. “It was not an election that was conducted the way I think that we want to, but that’s different than saying Maduro stole votes or something like that,” he added. “Those theories, you know, proved to be unsubstantiated.” Mr DeSantis, seen as the former president’s chief rival in the Republican primary, has in the past largely avoided direct criticisms of Mr Trump’s repeatedly disproven election claims. “We must reject the culture of losing that has impacted our party in recent years. The time for excuses is over,” Mr DeSantis said in a speech earlier this yer, before he formally announced his presidential campaign. “If we get distracted, if we focus the election on the past or on other side issues, then I think the Democrats are going to beat us again.” The former president’s repeated falsehoods are back in the spotlight, after Mr Trump was indicted this week for allegedly conspiring to overthrow the presidential election results. “The attack on our nation’s capitol on January 6, 2021, was an unprecedented assault on the seat of American democracy,” special counsel Jack Smith said on Tuesday, announcing the charges. “As described in the indictment, it was fueled by lies. Lies by the defendant targeted at obstructing a bedrock function of the US government – the nation’s process of collecting, counting and certifying the results of the presidential election.” This is a breaking news story and will be updated with new information. Read More College Board shelves AP psychology class in Florida over guidance on gender content Chris Christie meets Volodymyr Zelensky in surprise Ukraine visit NOT REAL NEWS: A look at what didn't happen this week

US employment increased at a solid pace in July while wages rose at a faster-than-expected clip, consistent with

If you love Uno, Mattel will pay you $277 an hour to play and promote their new game.

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

JPMorgan Chase & Co. economists scrapped their call for a recession in the US, joining a growing number

Alphabet Inc.’s Google will face a scaled-down antitrust suit over its search business after a federal judge threw

A New York judge declined to dismiss charges against Gregoire Tournant, a former Allianz SE hedge fund manager

Deforestation in the Brazilian Amazon fell by 66% last month compared to July 2022 and is now at its lowest rate in six years, according to preliminary data released by Brazil's National Institute for Space Research (INPE) on Thursday.

Indiana Pacers star Tyrese Haliburton is excited to compete on the world stage -- and potentially recruit a few star teammates to the midwest.The Indiana Pacers were on the verge of something special last season but ran into injuries. Now, with Tyrese Haliburton blossoming into stardom, a dynami...